The global COVID-19 pandemic has led to changes in public health measures causing significant disruption across lung cancer screening, diagnosis, treatment and management pathways. The pandemic has presented many challenges for lung cancer patients. These measures have also impacted people’s behaviour and their interaction with the healthcare system. Therefore, increased knowledge of the broader as well as biological impacts of COVID-19 on lung cancer patients’ health, is required.
Last week in BMC Nephrology, an article by Wang et al. looks at the use of multidisciplinary pre-dialysis care (MDPC) on peritonitis events, technique failure, and mortality. In this BMC Nephrology blog, Blog Editor Dr. Daphne Knicely will discuss the benefits of patient education programs on outcomes.
This year BMC Pediatrics traveled to Denver, Colorado to attend PAS 2022. PAS is an internationally renowned conference where Clinician, researchers, physician scientists and educators travel thousands of miles to share their research, develop new ideas, network with colleagues and build relationships for collaboration. As a result, the conference attracts up to 7,600 attendees and in 2022 presented hundreds of specialist talks and over 2,800 individual poster presentations.
Dr Raffaella Ravinetto is an Editorial Board Member of BMC Medical Ethics. A pharmacist by training, she is a senior researcher and policy advisor at the Institute of Tropical Medicine (ITM) in Antwerp, Belgium (www.itg.be) and an extraordinary professor at the School of Public Health, University of Cape Town, South Africa (Home – University of the Western Cape – School of Public Health (uwc.ac.za)). She is also the chairperson of the ITM Institutional Review Board, and of the Ethics Review Board of Médecins Sans Frontières.